(PharmaNewsWire.Com, March 01, 2017 ) Evolving Market Access Strategies - Pricing and Reimbursement Landscape in Major Developed Pharmaceutical Markets assesses developments within the key elements of market access such as Health Economics and Outcome Research (HEOR), Health Technology Assessment (HTA) as well as pricing and reimbursements strategies for pharmaceutical products.
New study analyses the role of HTAs in market access and alternatives that could be used in cases where there is limited evidence. Detailed analysis of pricing and reimbursement policies in North America, five key European countries and Japan are also included in this report along with a myriad of relevant case studies. In order to gain optimum Evolving market access, companies have to analyse the economic benefit of the treatment, the level of competition and the required reimbursement support.
Major TOC included in this Evolving Market Report:
· Health Economic and Outcomes Research (HEOR)
· A Systemic Value Development Plan for HEOR
· Health Technology Assessment (HTA) in Market Access
· Risk Sharing Agreements When Limited Evidence is Available for HTA
Key Reasons to Purchase this Evolving Market Report:
· Gain insights into current market access strategies and evolving approaches: This report describes fundamental concepts about market access, its key elements and the evolving landscape in key markets.
· Understand the role of HEOR in Evolving market access and pricing: This report provides insights about role of HEOR in market access and the different economic aspects measured in these studies.
· Understand HTA and its role in reimbursement: This includes detailed analysis on the benefits of HTA in Evolving market access, the various dimensions of HTA as well as case studies that highlight the role of these studies in the potential commercial success of a product.
· Review the involvement of Risk Sharing Agreements (RSAs) in Evolving market access: Includes details about the involvement of a RSA when there is limited evidence available for conducting HTAs as well as the various approaches involved in RSAs
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
